Integer Holdings Co. (NYSE:ITGR) Holdings Decreased by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. lowered its stake in Integer Holdings Co. (NYSE:ITGR) by 5.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 71,470 shares of the medical equipment provider’s stock after selling 4,124 shares during the quarter. Dana Investment Advisors Inc.’s holdings in Integer were worth $9,471,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ITGR. Geode Capital Management LLC lifted its stake in shares of Integer by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock worth $99,408,000 after acquiring an additional 9,421 shares during the period. Loomis Sayles & Co. L P raised its holdings in Integer by 3.0% during the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock worth $69,943,000 after purchasing an additional 15,446 shares in the last quarter. Congress Asset Management Co. lifted its position in Integer by 2.0% in the fourth quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider’s stock worth $66,041,000 after purchasing an additional 9,565 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in Integer by 1.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 408,588 shares of the medical equipment provider’s stock valued at $54,146,000 after purchasing an additional 4,559 shares in the last quarter. Finally, Lord Abbett & CO. LLC increased its position in shares of Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock valued at $37,716,000 after purchasing an additional 9,754 shares during the period. Institutional investors own 99.29% of the company’s stock.

Integer Trading Up 3.9 %

Integer stock opened at $122.87 on Thursday. The company has a 50 day moving average price of $136.01 and a 200 day moving average price of $132.95. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer Holdings Co. has a 52 week low of $107.11 and a 52 week high of $146.36. The firm has a market capitalization of $4.13 billion, a price-to-earnings ratio of 36.57, a P/E/G ratio of 1.72 and a beta of 1.13.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The business had revenue of $449.50 million for the quarter, compared to analysts’ expectations of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Research analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current year.

Analyst Upgrades and Downgrades

ITGR has been the subject of several research analyst reports. Truist Financial upped their price objective on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Benchmark upped their price target on shares of Integer from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, February 21st. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Finally, Citigroup lifted their price target on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $147.67.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.